BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Allergy to pollen
,
Liver
,
Holistic medicine
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
soluble guanylate cyclase
Summary
General Info
Curated Studies
Most Correlated Studies
Cord blood CD34+ cells treated with Riociguat
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of Gucy1a3 causes poor post-stroke recovery by reducing angiogenesis via the HIF-1α/VEGFA signa…
Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyam…
Moyamoya Disease 6 with Achalasia Due to GUCY1A3 Mutation in a Child.
FoxO4 controls sGCβ transcription in vascular smooth muscle.
Higher susceptibility to heme oxidation and lower protein stability of the rare α1C517Yβ1 sGC varian…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable…
A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects
Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ